Testing effectiveness (Phase 2)Study completedNCT02596074
What this trial is testing
Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN
Who this might be right for
Usual Type Vulval Intraepithelial Neoplasia (uVIN)
Maruho Co., Ltd. 12